FDA Announces Recall of Thousands of Bottles of Statin Drug Used for Cholesterol

Around 58,000 bottles of pitavastatin were recalled due to quality issues, according to the agency.

The U.S. Food and Drug Administration building in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

The U.S. Food and Drug Administration (FDA) on Thursday confirmed the recall of tens of thousands of bottles of a medication prescribed to treat high cholesterol.

In an enforcement report, the agency said that 57,504 bottles of 2-milligram pitavastatin tablets were voluntarily recalled by the manufacturer due to “failed impurities” or “degradation specifications,” which are terms used in the pharmaceutical industry to indicate that a drug or substance doesn’t meet the required quality standards.